Inventor · disambiguated record
William J. Hornback
Also filed as: HORNBACK WILLIAM J · HORNBACK WILLIAM JOSEPH · KALISH VINCENT J · RODRIGUEZ MICHAEL J
30 granted patents·1 pending application·413 citations·filing 1990–2009
97Inventor score
Top patents by PatentIndex Score
31 records- 0198US5484926AHIV protease inhibitorsAGOURON PHARMA·Filed 1994·Granted Jan 16, 1996·158 cites·8 claims
- 0290US8008301B2Histamine H3 receptor agents, preparation and therapeutic usesLILLY CO ELI·Filed 2009·Granted Aug 30, 2011·10 cites·14 claims
- 0390US5480887AProtease inhibitorsLILLY CO ELI·Filed 1994·Granted Jan 2, 1996·63 cites·12 claims
- 0486US5827891AHIV protease inhibtorsAGOURON PHARMA·Filed 1995·Granted Oct 27, 1998·36 cites·12 claims
- 0579US7632857B2Histamine H3 receptor agents, preparation and therapeutic usesLILLY CO ELI·Filed 2005·Granted Dec 15, 2009·4 cites·4 claims
- 0676US7173107B2Glycopeptide and preparation thereofLILLY CO ELI·Filed 2001·Granted Feb 6, 2007·7 cites·46 claims
- 0776US6037348AInhibition of viral replicationLILLY CO ELI·Filed 1997·Granted Mar 14, 2000·57 cites·5 claims
- 0874US7393868B2AMPA receptor potentiatorsLILLY CO ELI·Filed 2006·Granted Jul 1, 2008·3 cites·7 claims
- 0972US6693199B2Method of making HIV protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Feb 17, 2004·2 cites·23 claims
- 1072US6525215B2HIV protease inhibitorsAGOURON PHARMA·Filed 2001·Granted Feb 25, 2003·2 cites·1 claims
- 1169US8178528B2Histamine H3 receptor agents, preparation and therapeutic usesHIPSKIND PHILIP ARTHUR·Filed 2006·Granted May 15, 2012·1 cites·12 claims
- 1266US5834467AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Nov 10, 1998·11 cites·18 claims
- 1361US5952343AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Sep 14, 1999·8 cites·24 claims
- 1460US6127422AAnti-viral methodLILLY CO ELI·Filed 1997·Granted Oct 3, 2000·24 cites·8 claims
- 1560US2010029608A1Histamine H3 Receptor Agents, Preparation and Therapeutic UsesFINLEY DON RICHARD·Filed 2009·Application pending·0 cites
- 1655US7625932B2Pyrrole and pyrazole derivatives as potentiators of glutamate receptorsLILLY CO ELI·Filed 2004·Granted Dec 1, 2009·1 cites·10 claims
- 1751US7705025B2Histamine H3 receptor agents, preparation and therapeutic usesLILLY CO ELI·Filed 2005·Granted Apr 27, 2010·0 cites·18 claims
- 1851US5837710AHIV protease inhibitorsAGOURON PHARMA·Filed 1995·Granted Nov 17, 1998·4 cites·18 claims
- 1949US8008296B2Histamine H3 receptor agents, preparation and therapeutic usesLILLY CO ELI·Filed 2006·Granted Aug 30, 2011·0 cites·11 claims
- 2046US6162812APharmaceutical compositions containing HIV protease inhibitors and methods of their useAGOURON PHARMA·Filed 1999·Granted Dec 19, 2000·2 cites·8 claims
- 2145US6096917AAnti-viral compoundsLILLY CO ELI·Filed 1997·Granted Aug 1, 2000·3 cites·7 claims
- 2245US5272265A3-(substituted or unsubstituted) thiazolo-1-carba (1-dethia)cephemsLILLY CO ELI·Filed 1992·Granted Dec 21, 1993·2 cites·1 claims
- 2343US5179088A1-carba(dethia)cephalosporin antibioticsLILLY CO ELI·Filed 1990·Granted Jan 12, 1993·2 cites·18 claims
- 2442US7642361B2Thiophene and furan compoundsLILLY CO ELI·Filed 2005·Granted Jan 5, 2010·0 cites·5 claims
- 2542US5578608ASymmetrical diaryl and diheteroanyl cis epoxy alkanes antiviral compoundsLILLY CO ELI·Filed 1995·Granted Nov 26, 1996·2 cites·24 claims
- 2641US7666871B2Oxazole derivatives as histamine H3 receptor agents, preparation and therapeutic usesLILLY CO ELI·Filed 2005·Granted Feb 23, 2010·0 cites·17 claims
- 2741US6103922AAnti-viral compoundsLILLY CO ELI·Filed 1997·Granted Aug 15, 2000·2 cites·7 claims
- 2841US5099015ATrifluoromethyl 1-carba(1-dethia)cephemsLILLY CO ELI·Filed 1991·Granted Mar 24, 1992·4 cites·9 claims
- 2937US5734057AHIV protease inhibitors and intermediatesLILLY CO ELI·Filed 1996·Granted Mar 31, 1998·2 cites·9 claims
- 3036US6156924AAnti-viral compoundsLILLY CO ELI·Filed 1997·Granted Dec 5, 2000·1 cites·7 claims
- 3136US5624934AProtease inhibitorsLILLY CO ELI·Filed 1995·Granted Apr 29, 1997·2 cites·36 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →